Archived media:
- Webinar replay
McGuireWoods lawyers provided an in-depth analysis of the key business and legal considerations arising from corporate integrity agreements from the perspectives of healthcare, medical device and pharmaceutical companies who enter into them, and their various stakeholders.
Topics
- Common elements of a corporate integrity agreement
- Negotiating a corporate integrity agreement
- Maintaining and navigating compliance
- Analyzing impacts on the business
- Analyzing impacts on valuation and marketability
Speakers
- Christina M. Egan, Partner, McGuireWoods LLP
- Jeffrey E. Rogers, Partner, McGuireWoods LLP
- Helen H. Suh, Associate, McGuireWoods LLP
- Katherine C. Lin, Associate, McGuireWoods LLP